MX2015002705A - Compuestos de piridinona para usarse en terapia fotodinamica. - Google Patents
Compuestos de piridinona para usarse en terapia fotodinamica.Info
- Publication number
- MX2015002705A MX2015002705A MX2015002705A MX2015002705A MX2015002705A MX 2015002705 A MX2015002705 A MX 2015002705A MX 2015002705 A MX2015002705 A MX 2015002705A MX 2015002705 A MX2015002705 A MX 2015002705A MX 2015002705 A MX2015002705 A MX 2015002705A
- Authority
- MX
- Mexico
- Prior art keywords
- photodynamic therapy
- pyridinone compounds
- pyridinone
- compounds
- alkyl group
- Prior art date
Links
- 238000002428 photodynamic therapy Methods 0.000 title 1
- 150000005299 pyridinones Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/69—Two or more oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/81—Preparation or application process involves irradiation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Birds (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Un compuesto de Fórmula (I) o cualquier sal del mismo: (ver formula) en donde R1 es un grupo alquilo de 1 a 6 átomos de carbono, R2 es H o un grupo alquilo de 1 a 6 átomos de carbono, R3 es H o un grupo alquilo de 1 a 6 átomos de carbono, y n es un número entero desde 0 hasta 5.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1215675.8A GB201215675D0 (en) | 2012-09-03 | 2012-09-03 | Compound |
| PCT/GB2013/052297 WO2014033477A1 (en) | 2012-09-03 | 2013-09-02 | Pyridinone compounds for use in photodynamic therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2015002705A true MX2015002705A (es) | 2015-12-01 |
Family
ID=47075165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015002705A MX2015002705A (es) | 2012-09-03 | 2013-09-02 | Compuestos de piridinona para usarse en terapia fotodinamica. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9346758B2 (es) |
| EP (1) | EP2892881B1 (es) |
| JP (1) | JP2015526499A (es) |
| KR (1) | KR20150068374A (es) |
| CN (1) | CN104718190B (es) |
| AU (1) | AU2013308197B2 (es) |
| BR (1) | BR112015004732A2 (es) |
| CA (1) | CA2883754A1 (es) |
| GB (1) | GB201215675D0 (es) |
| IN (1) | IN2015DN02514A (es) |
| MX (1) | MX2015002705A (es) |
| RU (1) | RU2015111137A (es) |
| SG (1) | SG11201501604TA (es) |
| WO (1) | WO2014033477A1 (es) |
| ZA (1) | ZA201502153B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201215675D0 (en) | 2012-09-03 | 2012-10-17 | Univ Exeter | Compound |
| EP3148528A1 (en) | 2014-06-02 | 2017-04-05 | University of Exeter | Combinations of a photosensitizer with a hydrogen sulfide donor, thioredoxin inhibitor or nitroxide for use in photodynamic therapy |
| CN112062713B (zh) * | 2020-08-04 | 2023-03-31 | 浙江工业大学 | 具铁螯合性和pdt活性的ala-hpo杂合衍生物及其制备方法与应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9217099D0 (en) * | 1992-08-12 | 1992-09-23 | British Tech Group | Pharmaceutical compositions |
| US5895786A (en) * | 1996-05-08 | 1999-04-20 | New York Blood Center, Inc. | Method for treating viral infections |
| GB0018528D0 (en) * | 2000-07-27 | 2000-09-13 | Photocure Asa | Compounds |
| GB201215675D0 (en) | 2012-09-03 | 2012-10-17 | Univ Exeter | Compound |
-
2012
- 2012-09-03 GB GBGB1215675.8A patent/GB201215675D0/en not_active Ceased
-
2013
- 2013-09-02 WO PCT/GB2013/052297 patent/WO2014033477A1/en active Application Filing
- 2013-09-02 BR BR112015004732A patent/BR112015004732A2/pt not_active Application Discontinuation
- 2013-09-02 RU RU2015111137A patent/RU2015111137A/ru not_active Application Discontinuation
- 2013-09-02 JP JP2015529127A patent/JP2015526499A/ja active Pending
- 2013-09-02 US US14/425,385 patent/US9346758B2/en not_active Expired - Fee Related
- 2013-09-02 SG SG11201501604TA patent/SG11201501604TA/en unknown
- 2013-09-02 EP EP13771564.5A patent/EP2892881B1/en not_active Not-in-force
- 2013-09-02 CN CN201380053228.0A patent/CN104718190B/zh not_active Expired - Fee Related
- 2013-09-02 CA CA2883754A patent/CA2883754A1/en not_active Abandoned
- 2013-09-02 IN IN2514DEN2015 patent/IN2015DN02514A/en unknown
- 2013-09-02 KR KR1020157008471A patent/KR20150068374A/ko not_active Application Discontinuation
- 2013-09-02 MX MX2015002705A patent/MX2015002705A/es unknown
- 2013-09-02 AU AU2013308197A patent/AU2013308197B2/en not_active Ceased
-
2015
- 2015-03-30 ZA ZA2015/02153A patent/ZA201502153B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IN2015DN02514A (es) | 2015-09-11 |
| ZA201502153B (en) | 2017-07-26 |
| US9346758B2 (en) | 2016-05-24 |
| RU2015111137A (ru) | 2016-10-20 |
| AU2013308197A1 (en) | 2015-04-09 |
| EP2892881B1 (en) | 2017-07-19 |
| WO2014033477A1 (en) | 2014-03-06 |
| CA2883754A1 (en) | 2014-03-06 |
| SG11201501604TA (en) | 2015-05-28 |
| JP2015526499A (ja) | 2015-09-10 |
| US20150210642A1 (en) | 2015-07-30 |
| BR112015004732A2 (pt) | 2018-04-17 |
| KR20150068374A (ko) | 2015-06-19 |
| CN104718190B (zh) | 2017-03-08 |
| CN104718190A (zh) | 2015-06-17 |
| EP2892881A1 (en) | 2015-07-15 |
| GB201215675D0 (en) | 2012-10-17 |
| AU2013308197B2 (en) | 2018-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY164776A (en) | Heterocyclic compound | |
| IN2014DN07509A (es) | ||
| NZ705705A (en) | Ret inhibitor | |
| TN2014000122A1 (en) | 1 - arylcarbonyl - 4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases | |
| MX2016006336A (es) | Compuestos pirazolopirimidina. | |
| PH12015501316A1 (en) | Heterocyclic compound | |
| IN2014MN02598A (es) | ||
| TN2014000415A1 (en) | Novel thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof | |
| MX2014014531A (es) | Derivados de aminoquinazolina y piridopirimidina. | |
| GEP20156372B (en) | Pyridazinone compounds and their use as daao inhibitors | |
| MX368178B (es) | Compuestos de ácido dimetilbenzoico. | |
| MY170262A (en) | Dicarboxylic acid compound | |
| MX351863B (es) | Compuesto de anillo fusionado quinolilpirrolopirimidilo o sal del mismo. | |
| IN2014CN04449A (es) | ||
| UA113086C2 (xx) | Піразольні сполуки як інгібітори sglt1 | |
| JO3196B1 (ar) | عملية تحضير ملح ل – ارجينين البيريندوبريل | |
| JO3063B1 (ar) | مركب مبتكر وطرق لانتاجه | |
| IN2014DN06192A (es) | ||
| MX2016004967A (es) | Tratamiento para cancer pancreatico. | |
| MX369470B (es) | Medios y método para el tratamiento de tumores sólidos. | |
| MX2015002705A (es) | Compuestos de piridinona para usarse en terapia fotodinamica. | |
| MX359399B (es) | Inhibidores de 17alfa-hidroxilasa/c17-20-liasa. | |
| MX2014009084A (es) | Derivados de pirimidooxazocina como inhibidores de mtor. | |
| IN2014CN04922A (es) | ||
| MX358151B (es) | Derivado de sitaxentan. |